Mixed neuronal-glial tumor

Summary

Mixed neuronal-glial tumor (MONDO:0016729) is a cancer (an umbrella term covering 12 Mondo subtypes). A subtype of neuroepithelial neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer
• Umbrella term: 12 Mondo subtypes

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	mixed neuronal-glial tumor
Mondo ID	MONDO:0016729
Orphanet	251934
ICD-11	1792897751
NCIT	C4747
UMLS	C0474844
MedGen	105377
GARD	0020728
Is cancer (heuristic)	yes

Also known as: neuronal and Glio-neuronal neoplasm · neuronal and Glio-neuronal tumor · neuronal and Glio-neuronal tumour · neuronal and mixed neuronal-glial tumor · neuronal and mixed neuronal-glial tumors · neuronal and mixed neuronal-glial tumour · neuronal and mixed neuronal-glial tumours

Disease family

This is a subtype of neuroepithelial neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › nervous system neoplasm › neuroepithelial neoplasm › mixed neuronal-glial tumor

Related subtypes (5): primitive neuroectodermal tumor, papillary tumor of the pineal region, neuroepithelioma, glioma, pineal parenchymal cell neoplasm

Subtypes (12): ganglioneuroma, dysembryoplastic neuroepithelial tumor, extraventricular neurocytoma, gangliocytoma, desmoplastic infantile astrocytoma/ganglioglioma, ganglioglioma, papillary glioneuronal tumor, rosette-forming glioneuronal tumor of fourth ventricule, Lhermitte-Duclos disease, central neurocytoma, desmoplastic infantile astrocytoma, desmoplastic infantile ganglioglioma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.